An orally active reversible inhibitor of cathepsin S inhibits human trans vivo delayed-type hypersensitivity

This publication has 25 references indexed in Scilit:

• The Clinical Significance of Cathepsin S Expression in Human Astrocytomas
  The American Journal of Pathology, 2003
• The design of potent hydrazones and disulfides as cathepsin S inhibitors
  Bioorganic & Medicinal Chemistry, 2003
• Cytokines Regulate Proteolysis in Major Histocompatibility Complex Class II–Dependent Antigen Presentation by Dendritic Cells
  The Journal of Experimental Medicine, 2001
• Cysteine protease activity is up-regulated in inflamed ankle joints of rats with adjuvant-induced arthritis and decreases with in vivo administration of a vinyl sulfone cysteine protease inhibitor
  Arthritis & Rheumatism, 2001
• The role of lysosomal proteinases in MHC class Il‐mediated antigen processing and presentation
  Immunological Reviews, 1999
• Cathepsin S Controls the Trafficking and Maturation of Mhc Class II Molecules in Dendritic Cells
  The Journal of cell biology, 1999
• Trans vivo analysis of human delayed-type hypersensitivity reactivity
  Human Immunology, 1999
• Endosomal proteolysis and MHC class II function
  Current Opinion in Immunology, 1998
• Lysosomal processing of amyloid precursor protein to Aβ peptides: a distinct role for cathepsin S
  Biochemical Journal, 1995
• Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction?
  Annals of the Rheumatic Diseases, 1993